One of the issues of most concern during the development of paediatric medicinal products is that of clinical trials: only trials that are absolutely necessary should be carried out, and trials that have already produced results should not be repeated.
Aussi, il convient d'éviter de refaire des tests qui ont déjà donnés lieu à des résultats, ou d'en réaliser inutilement.